Rigel Pharmaceuticals Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$25.96

-0.14 (-0.54%)

As of Mar 22, 10:18 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 8 67%

Hold 4 33%

Sell 0 0%

Price Target

Analyst Price Target +108.4% upside

Low Target $39.68

Average Target $54.10

High Target $74.39

Current Price $25.96

Current
$25.96

Target
$54.10

$39.68 $54.10 avg $74.39

Scenario Analysis

Bear Case

$39.68

52.9%

Low target

Base Case

$54.10

+108.4%

Avg target

Bull Case

$74.39

+186.6%

High target

Risk/Reward

3.5x

Highly favorable

Price in Context

52-Week High

$52.24

-50.3% from high

52-Week Low

$15.50

+67.5% from low

Target vs 52W High

$54.10

+3.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%